NuVasive, Inc. (NUVA): Price and Financial Metrics


NuVasive, Inc. (NUVA): $43.62

-0.31 (-0.71%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NUVA POWR Grades

  • Growth is the dimension where NUVA ranks best; there it ranks ahead of 98.41% of US stocks.
  • The strongest trend for NUVA is in Growth, which has been heading up over the past 178 days.
  • NUVA ranks lowest in Sentiment; there it ranks in the 5th percentile.

NUVA Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, NUVASIVE INC is reporting a growth rate of -128.09%; that's higher than merely 12.32% of US stocks.
  • As for revenue growth, note that NUVA's revenue has grown 1.82% over the past 12 months; that beats the revenue growth of 25.87% of US companies in our set.
  • In terms of volatility of its share price, NUVA is more volatile than just 12.01% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to NUVASIVE INC are TCX, TRVG, NLS, MYGN, and CNMD.
  • Visit NUVA's SEC page to see the company's official filings. To visit the company's web site, go to www.nuvasive.com.

NUVA Valuation Summary

  • NUVA's price/sales ratio is 2.1; this is 61.82% lower than that of the median Healthcare stock.
  • Over the past 223 months, NUVA's price/earnings ratio has gone down 37.8.

Below are key valuation metrics over time for NUVA.

Stock Date P/S P/B P/E EV/EBIT
NUVA 2022-09-09 2.1 2.9 -60.6 -184.5
NUVA 2022-09-08 2.0 2.9 -60.0 -183.1
NUVA 2022-09-07 2.0 2.9 -58.9 -180.6
NUVA 2022-09-06 1.9 2.7 -55.9 -173.7
NUVA 2022-09-02 1.9 2.7 -56.3 -174.6
NUVA 2022-09-01 1.9 2.7 -55.5 -172.7

NUVA Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at 57.99%.
  • Its 2 year net income to common stockholders growth rate is now at -161.12%.
  • Its 5 year cash and equivalents growth rate is now at 143.08%.
Over the past 33 months, NUVA's revenue has gone up $28,081,000.

The table below shows NUVA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 1,174.124 170.87 -40.067
2022-03-31 1,158.501 157.074 -37.375
2021-12-31 1,138.988 182.174 -64.086
2021-09-30 1,128.72 217.483 -25.658
2021-06-30 1,153.166 232.2 1.853
2021-03-31 1,061.95 212.325 -49.961

NUVA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NUVA has a Quality Grade of C, ranking ahead of 59.67% of graded US stocks.
  • NUVA's asset turnover comes in at 0.477 -- ranking 99th of 186 Medical Equipment stocks.
  • DYNT, IRMD, and ELMD are the stocks whose asset turnover ratios are most correlated with NUVA.

The table below shows NUVA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.477 0.723 0.034
2021-03-31 0.418 0.697 0.001
2020-12-31 0.411 0.694 0.014
2020-09-30 0.454 0.700 0.027
2020-06-30 0.495 0.706 0.028
2020-03-31 0.595 0.731 0.088

NUVA Price Target

For more insight on analysts targets of NUVA, see our NUVA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $74.07 Average Broker Recommendation 1.75 (Moderate Buy)

NUVA Stock Price Chart Interactive Chart >

Price chart for NUVA

NUVA Price/Volume Stats

Current price $43.62 52-week high $64.43
Prev. close $43.93 52-week low $41.33
Day low $42.32 Volume 671,700
Day high $43.68 Avg. volume 567,100
50-day MA $48.75 Dividend yield N/A
200-day MA $51.81 Market Cap 2.27B

NuVasive, Inc. (NUVA) Company Bio


NuVasive develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company was founded in 1997 and is based in San Diego, California.


NUVA Latest News Stream


Event/Time News Detail
Loading, please wait...

NUVA Latest Social Stream


Loading social stream, please wait...

View Full NUVA Social Stream

Latest NUVA News From Around the Web

Below are the latest news stories about NUVASIVE INC that investors may wish to consider to help them evaluate NUVA as an investment opportunity.

NuVasive (NASDAQ:NUVA) Could Be At Risk Of Shrinking As A Company

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...

Yahoo | September 21, 2022

BTIG Keeps Their Hold Rating on NuVasive (NUVA)

E ratio of -55.35.

Carrie Williams on TipRanks | September 20, 2022

NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Scoliosis Research Society (SRS) as a double diamond sponsor and will attend the 57th Annual Meeting held September 14-17, 2022 in Stockholm, Sweden.

Yahoo | September 12, 2022

BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council

Top Executives Bring Expertise to Further Fuel Company Growth Tamara Elias, MD Tamara Elias, MD, joins the BrightInsight Advisory Council Scott Huennekens Scott Huennekens Joins the BrightInsight Advisory Council SAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennekens, e

Yahoo | September 7, 2022

NuVasive (NUVA) Down 16.2% Since Last Earnings Report: Can It Rebound?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 2, 2022

Read More 'NUVA' Stories Here

NUVA Price Returns

1-mo 0.09%
3-mo -14.27%
6-mo -22.55%
1-year -30.94%
3-year -33.97%
5-year -20.83%
YTD -16.88%
2021 -6.83%
2020 -27.17%
2019 56.05%
2018 -15.27%
2017 -13.17%

Continue Researching NUVA

Here are a few links from around the web to help you further your research on Nuvasive Inc's stock as an investment opportunity:

Nuvasive Inc (NUVA) Stock Price | Nasdaq
Nuvasive Inc (NUVA) Stock Quote, History and News - Yahoo Finance
Nuvasive Inc (NUVA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7604 seconds.